Literature DB >> 4245659

Coagulation disorders in cancer. 3. Fibrinolysis and inhibitors.

B C Soong, S P Miller.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4245659     DOI: 10.1002/1097-0142(197004)25:4<867::aid-cncr2820250417>3.0.co;2-c

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  11 in total

1.  Fibrinolytic activity of in vitro cultivated human bladder cell lines.

Authors:  H Hisazumi; L Andersson; V P Collins
Journal:  Urol Res       Date:  1977

2.  Incidence of paramalignant disorders in bronchogenic carcinoma.

Authors:  J W Rassam; G Anderson
Journal:  Thorax       Date:  1975-02       Impact factor: 9.139

3.  Urokinase inhibitor in patients with bladder cancer.

Authors:  H Hisazumi; K Naito; T Misaki; S Kosaka
Journal:  Urol Res       Date:  1974-12-20

4.  Fibrinolytic activity in malignant disease.

Authors:  J A Rennie; D Ogston
Journal:  J Clin Pathol       Date:  1975-11       Impact factor: 3.411

Review 5.  Hemostatic changes in patients with malignancy.

Authors:  G H Goldsmith
Journal:  Int J Hematol       Date:  2001-02       Impact factor: 2.490

6.  [Observations on tumor-associated fibrinolysis in human breast-cancer (author's transl)].

Authors:  R T Michel; H Schmidt-Matthiesen; D Nord; G Bastert; R Gerner
Journal:  Arch Gynakol       Date:  1975-12-16

7.  Postoperative venous thromboembolism and brain tumors: Part II. Hemostatic profile.

Authors:  R Sawaya; P Glas-Greenwalt
Journal:  J Neurooncol       Date:  1992-10       Impact factor: 4.130

8.  Thrombophlebitis migrans: a further systemic complication of ulcerative colitis.

Authors:  H L Elliott
Journal:  Postgrad Med J       Date:  1980-03       Impact factor: 2.401

Review 9.  Thromboembolic complications associated with brain tumors.

Authors:  R E Sawaya; B L Ligon
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

10.  Pulmonary embolism as the initial manifestation of large cell lung cancer--a case report with review.

Authors:  J K Kim; S M Lee; H T Kim; S Uh; Y Chung; Y H Kim; C Park; S Y Jin; D H Lee
Journal:  Korean J Intern Med       Date:  1992-07       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.